A share price of Aura Biosciences Inc [AURA] is currently trading at $6.38, up 4.42%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AURA shares have gain 18.15% over the last week, with a monthly amount glided 0.16%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On July 25, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $21 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating. JMP Securities started tracking with a Mkt Outperform rating for this stock on July 19, 2022, and assigned it a price target of $26.
Aura Biosciences Inc experienced fluctuations in its stock price throughout the past year between $4.34 and $9.53. Currently, Wall Street analysts expect the stock to reach $22.75 within the next 12 months. Aura Biosciences Inc [NASDAQ: AURA] shares were valued at $6.38 at the most recent close of the market. An investor can expect a potential return of 256.58% based on the average AURA price forecast.
Analyzing the AURA fundamentals
Gross Profit Margin for this corporation currently stands at -0.23% with Operating Profit Margin at -87.79%, Pretax Profit Margin comes in at -81.78%, and Net Profit Margin reading is -81.89%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -0.64 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.19 points at the first support level, and at 6.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.58, and for the 2nd resistance point, it is at 6.79.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aura Biosciences Inc [NASDAQ:AURA] is 9.04. As well, the Quick Ratio is 9.04, while the Cash Ratio is 7.23.
Transactions by insiders
Recent insider trading involved Hopkins Janet Jill, Officer, that happened on Nov 17 ’25 when 17109.0 shares were purchased. Chief Medical Officer, Hopkins Janet Jill completed a deal on Nov 17 ’25 to sell 17109.0 shares. Meanwhile, Officer Elazzouzi Amy bought 896.0 shares on Oct 29 ’25.
